End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.78 CNY | -0.34% |
|
-1.86% | -18.21% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 62% by 2026.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The firm trades with high earnings multiples: 29.27 times its 2024 earnings per share.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Electronic Equipment & Parts
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.21% | 1.18B | - | ||
+102.87% | 93.11B | B- | ||
+38.67% | 82.21B | B+ | ||
+11.46% | 39.75B | A- | ||
+9.49% | 36.84B | A+ | ||
-11.15% | 13.48B | B+ | ||
+33.48% | 11.69B | C- | ||
+6.28% | 11.4B | C | ||
+128.65% | 11.06B | - | ||
-3.82% | 10.91B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300602 Stock
- Ratings Shenzhen FRD Science & Technology Co., Ltd.